Mother-infant Signalling During Breastfeeding (MOMS)
Mother-infant Signalling During Breastfeeding: A Randomised Trial Investigating the Effects of a Relaxation Intervention in Breastfeeding Mothers on Breast Milk Production, Breast Milk Cortisol and Infant Behaviour and Growth.
Primary hypotheses
1. The use of a relaxation tape by breastfeeding mothers that will be given starting at week 2 postpartum, will result in : i) reduced maternal stress and anxiety ii) the production of a higher volume of breast milk iii) lower milk cortisol concentrations iv) favourable effects on infant behaviour (less crying, more sleeping) v) higher milk intake by the infant vi) more optimal growth, specifically higher lean mass and lower fat mass (body composition)
Secondary hypotheses (i) Infant temperament/behaviour and gender influence milk and energy intake and hence early growth and body composition (ii) Non-nutrient factors in breast milk (hormones including ghrelin and leptin) influence infant behaviour and feeding patterns and hence infant growth and body composition.
Descripción general del estudio
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Kuala Lumpur, Malasia
- Faculty of Medicine and Health Science, Universiti Putra Malaysia (UPM).
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
Primiparous mother with singleton pregnancy Infant is singleton and born at term (37-42 week of gestation) Infant birth weight of >2500 g (5,5 pounds or 5 pounds and 8,2 ounces) Mother and infant are generally healthy (free of serious illness that can affect breastfeeding or nursing infant, or energy balance of the infant).
No current or recent involvement in other research studies that could potentially affect any of outcome measures.
Mother speaks and understands either English only or English and Malay (some questionnaires are in English)
Exclusion Criteria:
Mother or baby has a major illness that affects nursing or breastfeeding, or affects energy balance of the infant.
Mother smokes Mothers who do not exclusively breastfeed their infant
-
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Control
Breastfeeding mothers who are not randomised to relaxation intervention
|
|
|
Experimental: Relaxation
Breastfeeding mothers randomised to use relaxation tape at 2 weeks post-partum
|
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Maternal stress and anxiety
Periodo de tiempo: Baselibne to 12 weeks
|
Maternal stress and anxiety assessed using the Cohen's Perceived Stress Scale (PSS) and Beck Anxiety Inventory (BAI) respectively (change in score from baseline to end-point at 12 weeks)
|
Baselibne to 12 weeks
|
|
Breast milk volume at 12 weeks assessed non-invasively using stable isotope techniques
Periodo de tiempo: 12 weeks
|
Breast milk volume at 12 weeks assessed non-invasively using stable isotope techniques
|
12 weeks
|
|
Breast milk cortisol concentrations at 12 weeks
Periodo de tiempo: 12 weeks
|
12 weeks
|
|
|
Infant behaviour measured using a 3-day diary at 12 weeks
Periodo de tiempo: 12 weeks
|
12 weeks
|
|
|
Infant weight and body composition measured using stable isotopes at 12 weeks
Periodo de tiempo: 12 weeks
|
12 weeks
|
|
|
Physiological changes (maternal saliva cortisol, breast milk cortisol and milk volume) before and after physiological-mini test in intervention group at 2,6 and 12 weeks.
Periodo de tiempo: 2,6,12 weeks
|
2,6,12 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Non-nutrient factors in breast milk - leptin and ghrelin
Periodo de tiempo: 2,6,12 weeks
|
2,6,12 weeks
|
|
Macronutrient composition of breast milk (fat and protein)
Periodo de tiempo: 2,6,12 weeks
|
2,6,12 weeks
|
Otras medidas de resultado
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Infant temperament measured using the Rothbart questionnaire
Periodo de tiempo: 12 weeks
|
12 weeks
|
|
Infant appetite assessed using the BEBQ
Periodo de tiempo: 2,6,12 weeks
|
2,6,12 weeks
|
|
Maternal depression assessed using Edinburgh Postnatal Depression Scale (EPDS)
Periodo de tiempo: 2 weeks
|
2 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Mary Fewtrell, MD, UCL Institute of Child Health, London
Publicaciones y enlaces útiles
Publicaciones Generales
- Mohd Shukri NH, Wells J, Eaton S, Mukhtar F, Petelin A, Jenko-Praznikar Z, Fewtrell M. Randomized controlled trial investigating the effects of a breastfeeding relaxation intervention on maternal psychological state, breast milk outcomes, and infant behavior and growth. Am J Clin Nutr. 2019 Jul 1;110(1):121-130. doi: 10.1093/ajcn/nqz033.
- Shukri NHM, Wells J, Mukhtar F, Lee MHS, Fewtrell M. Study protocol: An investigation of mother-infant signalling during breastfeeding using a randomised trial to test the effectiveness of breastfeeding relaxation therapy on maternal psychological state, breast milk production and infant behaviour and growth. Int Breastfeed J. 2017 Jul 14;12:33. doi: 10.1186/s13006-017-0124-y. eCollection 2017.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 13NT05
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .